ProShare Advisors’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1M | Buy |
21,336
+3,074
| +17% | +$144K | ﹤0.01% | 818 |
|
|
2025
Q1 | $806K | Sell |
18,262
-4,621
| -20% | -$204K | ﹤0.01% | 876 |
|
|
2024
Q4 | $827K | Buy |
22,883
+5,503
| +32% | +$199K | ﹤0.01% | 999 |
|
|
2024
Q3 | $557K | Buy |
17,380
+3,631
| +26% | +$116K | ﹤0.01% | 1079 |
|
|
2024
Q2 | $518K | Sell |
13,749
-3,724
| -21% | -$140K | ﹤0.01% | 953 |
|
|
2024
Q1 | $860K | Buy |
17,473
+2,368
| +16% | +$117K | ﹤0.01% | 833 |
|
|
2023
Q4 | $551K | Buy |
15,105
+3,440
| +29% | +$126K | ﹤0.01% | 985 |
|
|
2023
Q3 | $270K | Buy |
11,665
+40
| +0.3% | +$925 | ﹤0.01% | 1262 |
|
|
2023
Q2 | $305K | Buy |
11,625
+3,054
| +36% | +$80.1K | ﹤0.01% | 1262 |
|
|
2023
Q1 | $221K | Sell |
8,571
-1,223
| -12% | -$31.5K | ﹤0.01% | 1395 |
|
|
2022
Q4 | $255K | Buy |
9,794
+1,817
| +23% | +$47.3K | ﹤0.01% | 1329 |
|
|
2022
Q3 | $227K | Buy |
+7,977
| New | +$227K | ﹤0.01% | 1325 |
|
|
2022
Q2 | – | Sell |
-10,582
| Closed | -$597K | – | 2100 |
|
|
2022
Q1 | $597K | Sell |
10,582
-2,732
| -21% | -$154K | ﹤0.01% | 1170 |
|
|
2021
Q4 | $826K | Sell |
13,314
-923
| -6% | -$57.3K | ﹤0.01% | 1151 |
|
|
2021
Q3 | $903K | Sell |
14,237
-2,153
| -13% | -$137K | ﹤0.01% | 938 |
|
|
2021
Q2 | $1.35M | Buy |
16,390
+3,192
| +24% | +$263K | ﹤0.01% | 869 |
|
|
2021
Q1 | $971K | Buy |
13,198
+347
| +3% | +$25.5K | ﹤0.01% | 1001 |
|
|
2020
Q4 | $932K | Buy |
+12,851
| New | +$932K | ﹤0.01% | 911 |
|